Mobren Transport, Inc. – FDA 483, Nov 16, 2021
Mobren Transport Inc., an API manufacturer in Sioux City, IA, was cited with two observations during an FDA inspection. The firm failed to establish and meet appropriate specifications for crude heparin nano-concentrate, specifically lacking testing for impurities like over-sulfated chondroitin sulfate and non-porcine ruminant material. Additionally, their investigation into a customer complaint of foreign material in crude heparin was deemed inadequate as it did not extend to all potentially affected batches.
ID · e432bcdb-c6f7-4411-9234-f592082cf771
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.